Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

New agents for atherosclerosis from Bayer

May 30, 1997

Yamanouchi discloses Na+/H+ exchange inhibitors

May 30, 1997

Preliminary results from phase I trial of Nortran's RSD-921 reported

May 30, 1997

Use of labetalol in renal transplant patients discouraged

May 28, 1997

Clevidipine for controlling hypertension after CABG

May 27, 1997

ET antagonists disclosed by Merck KGaA

May 27, 1997

ETA antagonist effective against neointima formation in rabbit model

May 26, 1997

Y-26763 protects against ischemia/reperfusion injury in dog model

May 26, 1997

Pfizer sponsors large cardiovascular trial in U.K. and Scandinavia

May 26, 1997

Potent, nonpeptide ECE-1/NEP inhibitor discovered by Novartis

May 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...